Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity-Reference-Cited by-同舟云学术

Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity

Published:2013-01 Issue:1 Volume:23 Page:360-365
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Ruchelman Alexander L.,Man Hon-Wah,Zhang Weihong,Chen Roger,Capone Lori,Kang Jian,Parton Anastasia,Corral Laura,Schafer Peter H.,Babusis Darius,Moghaddam Mehran F.,Tang Yang,Shirley Michael A.,Muller George W.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference41 articles.

1. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

2. Thalidomide — A Revival Story

3. Thalidomide as an anti-cancer agent

4. Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses

5. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the complexity of drug resistance mechanisms to SINE, T cell-engaging therapies and CELMoDs in multiple myeloma: a comprehensive review;Cancer Drug Resistance;2024-06-26

2. Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation;Molecules;2024-06-11

3. Synthesis, characterization, anti‐proliferative evaluation, and molecular docking study of some new N‐(1, 3‐dioxoisoindolin‐4‐yl)acetamide derivatives;Journal of Heterocyclic Chemistry;2023-07-23

4. One-pot synthesis of diverse isoindolobenzoxazinone and isoindoloquinazolinone derivatives through a transition metal-free cascade cyclization;Journal of Molecular Structure;2023-06

5. N-Substituted (Hexahydro)-1H-isoindole-1,3(2H)-dione Derivatives: New Insights into Synthesis and Characterization;Processes;2023-05-25